Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
EVOK > SEC Filings for EVOK > Form 8-K on 7-Feb-2014All Recent SEC Filings

Show all filings for EVOKE PHARMA INC



Change in Directors or Principal Officers

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Base Salary Increases and Payment of Bonuses to Named Executive Officers

On February 6, 2014, the Board of Directors (the "Board") and the Compensation Committee (the "Committee") of the Board of Evoke Pharma, Inc. (the "Company") approved base salary increases for 2014 and cash bonus payments for the 2013 fiscal year to be paid to the Company's named executive officers. Under the Company's bonus program, the target performance bonus for David A. Gonyer, R.Ph., the Company's President and Chief Executive Officer, is 50% of base salary and the target bonus for Matthew J. D'Onofrio, the Company's Executive Vice President and Chief Business Officer, is 40% of base salary. Bonus payments were based on the Board's and the Committee's evaluation of performance goals for 2013. The base salary increases will be effective retroactively to January 1, 2014.

The 2014 base salaries and 2013 bonuses to be paid to each named executive officer are as follows:

 Name and Title                                   2014 Base Salary       2013 Bonus
 David A. Gonyer, R.Ph.,
 President and Chief Executive Officer            $         362,250     $    209,300

 Matthew J. D'Onofrio, Executive Vice President
 and Chief Business Officer                       $         313,875     $    145,080

  Add EVOK to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for EVOK - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.